ReShape Lifesciences
Price & Volume
Stats
See moreOpen | $0.38 |
Previous Close | $0.38 |
Day Range | $0.35-$0.38 |
52W Range | $0.38-$16.58 |
Market Cap | $3.6M |
Shares Short | 367,182 |
Financials
See moreRevenue (12 Mos) | $8M |
Revenue Growth (YoY) | -12.8% |
Gross Profit (12 Mos) | $6.8M |
Diluted EPS | $76.20 |
News
See moreYahoo Finance • 8 days ago
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FNA, AVTE, RSLS on Behalf of Shareholders
Yahoo Finance • 22 days ago
ReShape Lifesciences® Receives Notice of Allowance for U.S. Patent Related to Its Proprietary Diabetes Neuromodulation Technology
Yahoo Finance • last month
ReShape Lifesciences® Signs Distribution Agreement in Canada With Liaison Medical for its Next-Generation Lap-Band® 2.0 FLEX
Yahoo Finance • last month
ReShape Lifesciences® Announces Pricing of Upsized $6.0 Million Public Offering
About
CEO | Mr. Paul F. Hickey |
CFO | Mr. Thomas Stankovich |
Address | 18 Technology Drive, Irvine, CA, United States, 92618 |
Sector | Healthcare |
Industry | Medical Devices |
Full-Time Employees | 29 |
